Home Hospital for Bariatric Sleeve Gastrectomy

Sponsor
Brigham and Women's Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05259111
Collaborator
(none)
100
2
2
12.9
50
3.9

Study Details

Study Description

Brief Summary

Providing acute care at home for medicine patients is a well-studied care model. Providing acute care at home immediately following major surgery is less well understood. The investigators seek to demonstrate the noninferiority of care at home versus the hospital for patients undergoing bariatric sleeve gastrectomy.

Condition or Disease Intervention/Treatment Phase
  • Other: Home hospital
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Acute Care at Home for Adults Undergoing Bariatric Sleeve Gastrectomy: A Randomized Controlled Trial
Actual Study Start Date :
Feb 23, 2022
Anticipated Primary Completion Date :
Feb 23, 2023
Anticipated Study Completion Date :
Mar 23, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control, Care in the Hospital

After bariatric sleeve gastrectomy, patients receive their care in the hospital, as usual.

Experimental: Intervention, Care in the Home

After bariatric sleeve gastrectomy, patients receive their care in the home.

Other: Home hospital
Acute care provided at home, including nurse/paramedic visits, physician visits, laboratory testing, imaging, continuous monitoring, 24/7 urgent visits, and specialty consultation.

Outcome Measures

Primary Outcome Measures

  1. Length of Stay [From day of admission to day of discharge, assessed up to 10 months]

    Days spent hospitalized

Secondary Outcome Measures

  1. Motion [From day of admission to day of discharge, assessed up to 10 months]

    Percent of the day lying down

  2. Cost, direct [From day of admission to day of discharge, assessed up to 10 months]

    Presented as a percentage

  3. Opioid use [From day of admission to day of discharge, assessed up to 10 months]

    Morphine milligram equivalents used

Other Outcome Measures

  1. Rate of emergency department presentation [From day of discharge to 30 days later, assessed up to 10 months]

    Emergency department presentation without admission

  2. Rate of readmission [From day of discharge to 30 days later, assessed up to 10 months]

    Readmission to the hospital

  3. BodyQ Score [From day of admission to day of discharge, assessed up to 10 months]

    Sum of the following three transformed scales (total of 300 points): Satisfaction with information (100 points) + Satisfaction with doctor/surgeon (100 points) + Satisfaction with medical team (100 points)

  4. Picker experience questionnaire - 15 [From day of admission to day of discharge, assessed up to 10 months]

    0-15 points, more points better

  5. Global experience score [From day of admission to day of discharge, assessed up to 10 months]

    0-10 points, more points better

  6. Pain score [From day of admission to day of discharge, assessed up to 10 months]

    Pain score on scale of 0-10, fewer points better

  7. Number of complications [From day of admission to day of discharge, assessed up to 10 months]

    Sum of the complications included in the metabolic and bariatric surgery accreditation and quality improvement program

  8. Bed-days saved [From day of admission to day of discharge, assessed up to 10 months]

    Acute care bed days not required due to the intervention

  9. Stage 2 diet [From day of admission to day of discharge, assessed up to 10 months]

    Time to resumption of stage 2 diet, measured in hours

  10. 400mL intake [From day of admission to day of discharge, assessed up to 10 months]

    Time to intake of 400mL, measured in hours

  11. 6 hours out of bed on post operative day 1 [From day of admission to day of discharge, assessed up to 10 months]

    Time to 6 hours out of bed on post operative day 1, measured in hours

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All existing home hospital criteria apply, with the following taking precedent for this specific condition

  • 21-55 years old

  • Indication for bariatric laparoscopic sleeve gastrectomy per surgeon

  • Caregiver capable of communicating with the home hospital team and able to stay in the same home as the patient the first night the patient is home

Exclusion Criteria:
  • All existing home hospital criteria apply, with the following taking precedent for this specific condition

  • Comorbidities

  • Body mass index>55

  • Chronic kidney disease

  • Heart failure

  • History of

  • Chronic pain (with or without opioid use)

  • Substance use disorder

  • Venous thromboembolism

  • Stroke

  • Chronic headache

  • Medications

  • Anticoagulants and anti-platelets: aspirin, clopidogrel, warfarin, and direct oral anticoagulants

  • Beta blockade

  • Immunosuppressive

  • Supplemental oxygen

  • Allergy to ketorolac

  • Prolonged QTc

Contacts and Locations

Locations

Site City State Country Postal Code
1 Brigham and Women's Faulkner Hospital Boston Massachusetts United States 02130
2 Brigham and Women's Hospital Boston Massachusetts United States 02130

Sponsors and Collaborators

  • Brigham and Women's Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
David Levine, Associate Physician, Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT05259111
Other Study ID Numbers:
  • 2017P002583e
First Posted:
Feb 28, 2022
Last Update Posted:
Mar 2, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Mar 2, 2022